Phase II study of90Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma-Reference-Cited by-同舟云学术

Phase II study of90Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma

Published:2014-11-20 Issue:6 Volume:56 Page:1750-1755
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Lossos Izidore S.,Fabregas Jesus C.,Koru-Sengul Tulay,Miao Feng,Goodman Deborah,Serafini Aldo N.,Hosein Peter J.,Stefanovic Alexandra,Rosenblatt Joseph D.,Hoffman James E.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2014.975801

Reference34 articles.

1. Long-Term Results of Anti– Helicobacter pylori Therapy in Early-Stage Gastric High-Grade Transformed MALT Lymphoma

2. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

3. Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radioimmunotherapy;Precision Cancer Therapies vol 2 ‐ Immunologic Approaches for the Treatment of Lymphoid Malignancies ‐ From Concept to Practice;2024-02-21

2. Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas;Clinical Lymphoma Myeloma and Leukemia;2023-04

3. A Phase II Study of ¹³¹I-rituximab for Patients With Relapsed or Refractory Marginal Zone Lymphoma;Clinical Medicine Insights: Oncology;2023-01

4. Nodales Marginalzonenymphom;Indolente Lymphome;2023

5. Primary Gastric Lymphoma;The AFS Textbook of Foregut Disease;2023